The report provides detailed analysis essential for establishing a dextromethorphan production plant. It encompasses all critical aspects necessary for dextromethorphan production, including the cost of dextromethorphan production, dextromethorphan plant cost, dextromethorphan production costs, and the overall dextromethorphan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a dextromethorphan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dextromethorphan is a widely used medicinal compound that finds important applications in the healthcare and pharmaceutical industries. It is mainly utilised as a cough suppressant in many over-the-counter cold and flu medicines, which helps to reduce dry and irritating coughs. It is commonly found in syrups, tablets, lozenges, and combination formulations used for respiratory infections. It helps reduce coughing by affecting signals in the brain that trigger the cough reflex. In addition to cough relief, it is also sometimes used in certain prescription treatments for neurological conditions, as it can affect brain signalling pathways. Moreover, it is also included in research and development for pain management and mood-related therapies due to its action on the central nervous system.
The primary factor that drives the market for dextromethorphan is its application as a cough suppressant in over-the-counter cold and flu medications, which boosts its demand in the pharmaceutical industry. Its application as an antitussive for suppressing cough significantly contributes to its demand in the medical and pharmaceutical industry. Its usage as an over-the-counter (OTC) cough suppressant in combination with cold medications for fever, nasal congestion, or sore throat also promotes its demand in the pharmaceutical industry.
Its involvement in controlled settings to explore its effects on brain function and its potential in treating certain neurological conditions also supports its demand in the medical research industry. Its demand in production cough control products further drives its market growth. Industrial dextromethorphan procurement is largely influenced by factors such as the cost and availability of key raw materials, adherence to pharmaceutical-grade production standards, regulatory approvals, and consistency in supply chains. Furthermore, innovations in formulation technologies, growing demand from emerging markets, and focus on quality control and compliance also play an important role in shaping its global procurement processes.
Raw Material for Dextromethorphan Production
According to the dextromethorphan production plant project report, the major raw materials for dextromethorphan production include (±)-3-hydroxy-N-methylmorphinane, phenyltrimethylammonium chloride, sodium methoxide, and D-tartaric acid.
Production Process of Dextromethorphan
The extensive dextromethorphan production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of dextromethorphan begins with (±)-3-hydroxy-N-methylmorphinane, which undergoes methylation to replace the hydroxyl group on the aromatic ring with a methoxy group. The reaction is performed using phenyltrimethylammonium chloride and sodium methoxide in methanol, which forms (±)-3-methoxy-N-methylmorphinane, as the intermediate compound. Then, the racemic mixture is separated using D-tartaric acid, which selectively crystallises the desired isomer and results in the production of dextromethorphan as the final product.
Dextromethorphan is a synthetic morphinan derivative commonly used as a cough suppressant and antitussive agent. It appears as an odourless, opalescent white powder in its pure form. The molecular formula of the compound is C18H25NO, and its molar mass is 271.40 g/mol. It has a density of approximately 1.01 g/cm³, and its melting point is around 80 degree Celsius. The boiling point of the compound is approximately 414 degree Celsius, and its flash point is around 9 degree Celsius. The compound is insoluble in water but is freely soluble in chloroform and soluble in ethanol. It primarily acts as an NMDA receptor antagonist and a sigma-1 receptor agonist. The compound can produce dissociative and hallucinogenic effects when used in excess of recommended dosages. It is recommended to use this compound only as directed, as misuse or abuse may lead to serious adverse effects, including serotonin syndrome, respiratory depression, and central nervous system disturbances.